Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autoinflammatory disease caused by mutations in the NLRP12 gene. It is characterized by periodic fevers beginning in the first year of life that are triggered by cold exposure. Episodes occur more than once per month.
Features include always present findings: Elevated erythrocyte sedimentation rate, Elevated CRP (inflammation marker) (elevated circulating c-reactive protein concentration), Recurrent fever, and Elevated white blood cell count (increased total leukocyte count); and very common findings: Urticaria and Arthralgia. 18 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 3 | Urticaria, Erythema nodosum, Skin rash |
NLRP12 encodes NLR family pyrin domain containing 12 (1,061 aa). Plays an essential role as an potent mitigator of inflammation. Highest expression in Whole Blood (34.0 TPM) and Spleen (7.7 TPM).
Familial cold autoinflammatory syndrome 2 is associated with mutations in the NLRP12 gene on chromosome 19.
NLRP12 is classified as a druggable target with score 0.0.
Genetic testing for NLRP12 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 2 very common features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial cold autoinflammatory syndrome 2.
7 publications have been identified in PubMed for familial cold autoinflammatory syndrome 2. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (33%), and Basic Science / Preclinical (17%).
Bouramtane A (2026). [PMID: 41261519](https://pubmed.ncbi.nlm.nih.gov/41261519/). *Int J Immunogenet*. [Review / Meta-Analysis]
Lizama-Muñoz A (2026). [PMID: 42099593](https://pubmed.ncbi.nlm.nih.gov/42099593/). *Front Immunol*. [Case Report / Case Series]
Ruíz-Santana JE (2026). [PMID: 42157874](https://pubmed.ncbi.nlm.nih.gov/42157874/). *Case Rep Med*. [Case Report / Case Series]
Vatandoost N (2025). [PMID: 40556386](https://pubmed.ncbi.nlm.nih.gov/40556386/). *Int J Immunogenet*. [Review / Meta-Analysis]
Nadendla EK (2025). [PMID: 40408404](https://pubmed.ncbi.nlm.nih.gov/40408404/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 1:47 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Bones and joints | 2 | Arthralgia, Joint inflammation (arthritis) |
Digestive system | 2 | Abdominal pain, Enlarged spleen (splenomegaly) |
Blood and immune system | 2 | Enlarged spleen (splenomegaly), Elevated white blood cell count (increased total leukocyte count) |
Arms and legs | 1 | Lower limb pain |
Lab test results | 1 | Elevated CRP (inflammation marker) (elevated circulating c-reactive protein concentration) |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Metabolism | 1 | Recurrent fever |
Brain and nerves | 1 | Headache |
Muscles | 1 | Myalgia |
Zhou N (2025). [PMID: 41464195](https://pubmed.ncbi.nlm.nih.gov/41464195/). *Diagnostics (Basel)*. [Review / Meta-Analysis]